Cellebrite DI Ltd.

Cellebrite DI Ltd.

CLBT
Cellebrite DI Ltd.US flagNASDAQ Global Select
11.37
USD
-0.13
- -
2.84BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.92
1.04
1.71
1.48
1.71
1.92
1.97
2.09
Basic EPS, GAAP
-0.05
-0.05
0.5
0.66
-0.43
-1.35
0.32
0.24
Free Cash Flow per Basic Share
0.05
0.32
0.19
0.06
0.5
0.58
0.66
0.52
Dividend per Share
0.13
0.05
0.69
- -
- -
- -
- -
- -
Book Value per Share
0.31
0.34
-0.39
0.38
0.17
1.43
1.95
2.15
Tangible Book Value per Share
0.31
0.26
-0.59
0.19
-0.02
1.26
1.14
1.18
Basic Weighted Avg Shares
187
187
144
183
190
209
242
246
Sales/Revenue/Turnover
172
195
246
271
325
401
476
514
Operating Margin (%)
-0.88
4.73
5.61
0.39
10.22
14.18
13.98
10.86
Depreciation Expense
4
6
7
9
10
11
12
23
Net Income, GAAP
-2
6
71
121
-81
-283
78
59
Effective Tax Rate (%)
232.58
49.28
13.25
- -
- -
- -
13.62
22.05
Profit Margin (%)
-1.09
2.97
28.99
44.63
-24.95
-70.54
16.47
11.43
Working Capital
163
165
87
88
168
272
206
225
LT Debt
- -
- -
- -
10
9
7
19
17
Total Equity
59
64
-73
74
34
336
484
538
Return on Invested Capital (%)
- -
7.23
- -
- -
- -
- -
13.36
8.79
Return on Capital (%)
- -
9.43
-1,499.08
- -
- -
- -
18.45
11.85
Return on Common Equity (%)
- -
-15.24
133.73
87.01
-150.08
-152.88
19.1
12.42

Capital Structure

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4
5
6
LT Borrowings
- -
- -
- -
LT Finance Leases
19
18
17
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
249
249
251
Market Capitalization
4,482
3,437
3,661

Working Capital

FRC

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
576
541
590
Cash, Cash Equivalents & STI
437
429
443
Accounts Receivable, Net
105
73
111
Inventories
8
8
8
Total Current Liabilities
370
350
364
Payables & Accruals
87
91
95
ST Debt
4
5
6
Deferred Revenue
278
255
263

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
91.39%
44.13%
Free Cash Flow
- -
133.53%
31.88%
Net Income, GAAP
- -
231.67%
-127.68%
Sales/Revenue/Turnover
- -
19.67%
18.56%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
90
96
107
109
401
2025
108
113
126
129
476
2026
128
131
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.36
-0.12
-0.99
0.08
-1.35
2025
0.07
0.08
0.08
0.09
0.32
2026
0.04
0.03
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Shiv Ramji
Full Time Employees
1,285
Sector
Technology
Industry
Software - Infrastructure
Address
94 Shlomo Shmelzer Road Petah Tikva HM Israel 4970602
IPO Date
Nov 6, 2020
Business
Cellebrite DI Ltd. Cellebrite DI Ltd. (Nasdaq:CLBT), founded in 1999 and headquartered in Petah Tikva, Israel, provides digital intelligence solutions for legally sanctioned investigations to law enforcement, intelligence agencies, military branches, enterprises, and corporations worldwide; operates across Europe, the Middle East, Africa, the Americas, and Asia-Pacific; offers a comprehensive Digital Intelligence platform including the flagship Cellebrite UFED for mobile device data extraction from over 30,000 devices, Pathfinder for advanced investigations and data analytics, Guardian SaaS suite for case management with new EU data-residency region and expanded Android/iOS collection via Inseyets, solutions for cloud data, social media, computers, drones, and open-source intelligence; provides training services, cybersecurity, and incident response capabilities. Cellebrite's core offerings encompass forensic extraction, review, analysis, decoding, decryption, sharing, and management of digital evidence across the investigative lifecycle for cases including child exploitation, homicide, terrorism, organized crime, human trafficking, corporate security, cryptocurrency investigations, and intellectual property theft. The company recently agreed to acquire Corellium, a developer of Arm-based virtualization software for mobile vulnerability research, DevSecOps, and virtual device testing, in a $170 million cash deal plus up to $30 million contingent consideration, expected to close in 2025; acquired Cyber Technology Services (CyTech) in 2024 to bolster U.S. federal capabilities through newly formed Cellebrite Federal Solutions with FedRAMP High pursuit and U.S. Department of Justice sponsorship; launched Autumn 2025 product releases featuring Guardian Investigate (limited production with general availability in early 2026), AWS GovCloud deployment for Pathfinder, expanded NCMEC CyberTipline integration in Inseyets for faster CSAM matching, and Corellium tooling subscriptions by defense customers in EMEA and APAC; appointed permanent CEO Thomas Hogan following interim leadership and Yossi Carmil's retirement. Cellebrite remains majority-owned by Japan-based Sun Corporation, employs over 1,100 people, and reports subscription revenue growth of 21% year-over-year in recent quarters with recurring revenue forming the bulk of its business.

Company News

  • Cellebrite Calls for 2027 JUSTYS Nominees, Premier Event Highlights Unsung Heroes Who Keep the World Safe

  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellebrite DI Ltd. – CLBT

  • Kaplan Fox Notifies Investors of Cellebrite DI Ltd. (CLBT) of a Securities Law Investigation

  • Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm Regarding a Securities Investigation

  • Squarepoint Ops LLC Sells 66,713 Shares of Cellebrite DI Ltd. $CLBT

  • Cellebrite erweitert seine globale digitale Community „The 101" für Fachleute aus den Bereichen digitale Forensik und Ermittlungsarbeit

  • Cellebrite développe « The 101 », sa plateforme numérique mondiale destinée à la communauté des professionnels des enquêtes et de la criminalistique numériques

  • CLBT Investors Have Opportunity to Join Cellebrite DI Ltd. Fraud Investigation with SBS Law

  • Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals

  • Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (CLBT) to a Securities Law Investigation

  • Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript

  • Kaplan Fox Announces an Investigation into Cellebrite DI Ltd. (CLBT) on Behalf of Investors

  • Chris Wade, director de tecnología de Cellebrite, liderará Cellebrite Labs

  • Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research

  • Cellebrite Initiates Plans to Redomicile in the United States

  • Kaplan Fox Encourages Cellebrite DI Ltd. (CLBT) Investors Who Suffered Losses to Contact the Firm About the Securities Investigation

  • Kaplan Fox Urges Cellebrite DI Ltd. (CLBT) Investors to Contact the Firm About Possible Securities Law Violations

  • Cellebrite DI (NASDAQ:CLBT) and Riskified (NYSE:RSKD) Head to Head Contrast

  • Kaplan Fox Encourages Investors of Cellebrite DI Ltd. (CLBT) to Contact the Firm to Learn About Their Legal Rights

  • Cellebrite kündigt für September bevorstehende Investorenveranstaltungen an